MONMOUTH JUNCTION, N.J: CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that its Chief Executive Officer, Dr. Phillip Chan, MD, PhD, will give a corporate update and discuss goals for 2018 at the Biotech Showcase 2018 conference on Tuesday, January 9, 2018 at 11:00 AM PST in San Francisco, California.
Dr. Chan will be joined by Kathleen Bloch, Chief Financial Officer, Vincent Capponi, Chief Operating Officer, and Chris Cramer, Vice President of Business Development during the informal question and answer session that will follow.
Conference Presentation Details:
Where: Hilton San Francisco Union Square, 333 O'Farrell Street, San Francisco, CA 94102
When: Tuesday, January 9, 2018 at 11:00 AM PST
Room: Franciscan A - Ballroom Level
Webcast: https://event.webcasts.com/starthere.jsp?ei=1176804&tp_key=b53d5c2057
Conference Website: Biotech Showcase 2018
CytoSorbents' management will host one-on-one meetings with investors in San Francisco from January 8-10, 2017 but have limited availability due to other meetings. To meet with the Company at Biotech Showcase, please submit a meeting request for January 9, 2017 via the PartneringOne scheduling system, or contact Karen Davis at kdavis@lifesciadvisors.com for other meeting dates.
